• Wed. Jun 12th, 2024

Type 1 diabetes is no match for this gymnast


Mar 27, 2024

The FDA recently approved a device for diabetics called the “bionic pancreas,” which can help take the burden of continually entering carb intake off the user. This revolutionary device allows users to simply input the size of their next meal, and an AI algorithm determines the precise amount of insulin needed to keep blood sugar stable. This new technology has been life-changing for 15-year-old Mia Campos, a skilled gymnast from San Antonio who has been living with type 1 diabetes for five years.

Mia was diagnosed with diabetes during a gymnastics competition when she began experiencing symptoms like excessive thirst and frequent urination. She was fitted with a traditional insulin pump which required constant programming and often experienced glitches. Fortunately, her pediatric endocrinologist recommended the “bionic pancreas,” which has now been cleared by the FDA for commercial use. This device is clipped to her jeans and uses AI software to tailor insulin delivery to her glucose levels.

The iLet device, approved for use in individuals aged six and up, requires just one input regarding the size of the user’s next meal. The device then learns the user’s biorhythms and delivers insulin accordingly, keeping blood sugar levels stable. Mia is thrilled with the benefits of the device, allowing her to focus on her homework and gymnastics training rather than constantly worrying about her carb intake and insulin levels.

The “bionic pancreas” uses a plastic infusion set attached to the body to communicate with sensors and deliver insulin as needed. Dr. Lynch, Mia’s pediatric endocrinologist, emphasizes that diet and exercise are still critical components of managing blood sugar levels. Mia believes that this new technology will greatly benefit individuals, particularly children, who have busy lives and struggle to manually track their carb intake.

By editor

Leave a Reply